Explore more publications!
Bay State Times
Got News to Share?

Bay State Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bay State Times.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 1, 2025

Alpha Tau to Participate in December Investor Conferences
December 1, 2025

Alpha Tau to Participate in December Investor Conferences

Indeterminate GlobeNewswire
ConnectM Delivers on Turnaround Plan: Back to OTCQB and Aiming for National Exchange Uplisting
December 1, 2025

ConnectM Delivers on Turnaround Plan: Back to OTCQB and Aiming for National Exchange Uplisting

Indeterminate GlobeNewswire
Akamai Technologies Announces Acquisition of Function-as-a-Service Company Fermyon
December 1, 2025

Akamai Technologies Announces Acquisition of Function-as-a-Service Company Fermyon

Indeterminate GlobeNewswire
Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia
December 1, 2025

Solid Biosciences Receives FDA Rare Pediatric Disease Designation for SGT-212 Dual Route of Administration Gene Therapy for Friedreich’s Ataxia

Indeterminate GlobeNewswire
Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference
December 1, 2025

Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference

Indeterminate GlobeNewswire
Peer To Peer Network Releases Q&A Call Summary Regarding Launch of PTOP Intelligence Labs
December 1, 2025

Peer To Peer Network Releases Q&A Call Summary Regarding Launch of PTOP Intelligence Labs

Indeterminate GlobeNewswire
Cerence AI to Participate in Raymond James TMT and Consumer Conference
December 1, 2025

Cerence AI to Participate in Raymond James TMT and Consumer Conference

Indeterminate GlobeNewswire
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
December 1, 2025

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

Indeterminate GlobeNewswire
Tectonic Therapeutic to Participate in December Investor Conferences
December 1, 2025

Tectonic Therapeutic to Participate in December Investor Conferences

Indeterminate GlobeNewswire
Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
December 1, 2025

Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting

Indeterminate GlobeNewswire
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
December 1, 2025

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
December 1, 2025

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Indeterminate GlobeNewswire
Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025
December 1, 2025

Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025

Indeterminate GlobeNewswire
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
December 1, 2025

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Indeterminate GlobeNewswire
Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)
December 1, 2025

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

Indeterminate GlobeNewswire
Akebia Announces Establishment of Rare Kidney Disease Pipeline
December 1, 2025

Akebia Announces Establishment of Rare Kidney Disease Pipeline

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions